Cellular and molecular determinants of altered Ca 2ϩ handling in the failing rabbit heart: primary defects in SR Ca 2ϩ uptake and release mechanisms. Am J Physiol Heart Circ Physiol 292: H1607-H1618, 2007. First published November 22, 2006; doi:10.1152/ajpheart.00525.2006.-Myocytes from the failing myocardium exhibit depressed and prolonged intracellular Ca 2ϩ concentration ([Ca 2ϩ ]i) transients that are, in part, responsible for contractile dysfunction and unstable repolarization. To better understand the molecular basis of the aberrant Ca 2ϩ handling in heart failure (HF), we studied the rabbit pacing tachycardia HF model. Induction of HF was associated with action potential (AP) duration prolongation that was especially pronounced at low stimulation frequencies. L-type calcium channel current (ICa,L) density (Ϫ0.964 Ϯ 0.172 vs. Ϫ0.745 Ϯ 0.128 pA/pF at ϩ10 mV) and Na ϩ /Ca 2ϩ exchanger (NCX) currents (2.1 Ϯ 0.8 vs. 2.3 Ϯ 0.8 pA/pF at ϩ30 mV) were not different in myocytes from control and failing hearts. The amplitude of peak [Ca 2ϩ ]i was depressed (at ϩ10 mV, 0.72 Ϯ 0.07 and 0.56 Ϯ 0.04 M in normal and failing hearts, respectively; P Ͻ 0.05), with slowed rates of decay and reduced Ca 2ϩ spark amplitudes (P Ͻ 0.0001) in myocytes isolated from failing vs. control hearts. Inhibition of sarco(endo)plasmic reticulum Ca 2ϩ -ATPase (SERCA)2a revealed a greater reliance on NCX to remove cytosolic Ca 2ϩ in myocytes isolated from failing vs. control hearts (P Ͻ 0.05). mRNA levels of the ␣1C-subunit, ryanodine receptor (RyR), and NCX were unchanged from controls, while SERCA2a and phospholamban (PLB) were significantly downregulated in failing vs. control hearts (P Ͻ 0.05). ␣1C protein levels were unchanged, RyR, SERCA2a, and PLB were significantly downregulated (P Ͻ 0.05), while NCX protein was significantly upregulated (P Ͻ 0.05). These results support a prominent role for the sarcoplasmic reticulum (SR) in the pathogenesis of HF, in which abnormal SR Ca 2ϩ uptake and release synergistically contribute to the depressed [Ca 2ϩ ]i and the altered AP profile phenotype.
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calcium; ion channels; sarcoplasmic reticulum; pacing tachycardia THE REDUCED CONTRACTILITY and altered repolarization of the failing human heart and many animal models of heart failure (HF) are, in part, the result of abnormal intracellular Ca 2ϩ cycling (4, 34, 35, 57, 58, 66) . However, despite extensive investigation, the precise molecular mechanisms responsible for altered Ca 2ϩ handling in the failing heart remain controversial. Although there is a general consensus that sarcoplasmic reticulum (SR) Ca 2ϩ handling is abnormal in HF, some studies suggest that these abnormalities are primarily the result of the abnormal density/function of Ca 2ϩ uptake and extrusion mechanisms [i.e., sarco(endo)plasmic reticulum Ca 2ϩ -ATPase (SERCA)2a and Na ϩ /Ca 2ϩ exchanger (NCX)] (34, 66) , while others attribute these abnormalities primarily to alterations in SR Ca 2ϩ release [via the SR Ca 2ϩ release channel, ryanodine receptor (RyR)] (57, 58, 75) . Furthermore, while the different animal models of HF exhibit a similar phenotype reminiscent of human HF, emerging information supports the notion that the common phenotype of HF may represent a final common pathway for unique model (or injury)-specific molecular phenotypes.
The pacing-induced HF model is characterized by abnormal ␤-adrenergic receptor signaling (46) and elevated reninangiotensin-aldosterone stimulation (56) that result in chamber dilation with markedly elevated diastolic pressures, depressed systolic function (83) , and increased apoptosis (48) . Thus we hypothesized that in a pacing-induced HF model the altered autonomic tone results in abnormal SR Ca 2ϩ release and related defects in SR Ca 2ϩ uptake as the primary mechanism of abnormal Ca 2ϩ homeostasis. To better understand the mechanisms responsible for abnormal Ca 2ϩ homeostasis and cellular electrophysiology, we studied the L-type Ca 2ϩ (I Ca,L ) and NCX currents, whole cell intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) transients, local Ca 2ϩ transients (i.e., Ca 2ϩ sparks), and mRNA and protein levels of the major Ca 2ϩ -handling molecules in the rabbit pacing-induced HF model.
To examine the hypothesis that the failing myocyte phenotype, manifested by depressed Ca 2ϩ transients and potentially arrhythmogenic prolonged action potential (AP) duration (APD), is the result of a single mechanism versus a multiplicity of mechanisms, we used a comprehensive approach to isolate and study the molecular and functional phenotype of potentially abnormal Ca 2ϩ homeostatic processes, involving the primary Ca 2ϩ entry, release, uptake, and extrusion mechanisms in myocytes from failing hearts.
METHODS
Rabbit pacing-induced HF model. Nine New Zealand White rabbits of either sex underwent sterile implantation of a bipolar pacemaker. Rabbits were anesthetized with intravenous thiopental sodium, intubated, and volume ventilated. A laparotomy was performed, and the diaphragm and the pericardium were opened to expose the heart. Two custom-made pacing wires were placed in the apex of the heart. A VVI pacemaker (Minix 8340 or Thera SR 8962, Medtronic) was inserted into a pocket formed between the abdominal muscles. Rapid pacing was maintained by permanently attaching a magnet to the posterior surface of the pacemaker pulse generator. Animals were allowed to recover from surgery for 3-4 days, after which pacing was initiated at 400 beats/min for 2-4 wk. Heart failure was verified by transthoracic echocardiography. After 2.5 Ϯ 0.7 wk of pacing, the left ventricular end-diastolic diameter increased (normal 13 Ϯ 3 mm vs. failing 18 Ϯ 3 mm; P Ͻ 0.05), left ventricular end-diastolic pressure increased (normal 2.0 Ϯ 3 mmHg vs. failing 19.0 Ϯ 7.1 mmHg; P Ͻ 0.05), systolic fractional shortening (in % of end-diastolic diameter) decreased (normal 46 Ϯ 8% vs. failing 21 Ϯ 7%; P Ͻ 0.05), and the rate of pressure rise decreased (normal 6,900 Ϯ 1,620 mmHg/s vs. failing 3,600 Ϯ 270 mmHg/s; P Ͻ 0.05), consistent with severe HF (35) . All procedures involving animals were approved by the Institutional Animal Care and Use Committee of the Johns Hopkins University.
Isolation of ventricular myocytes. Isolated myocytes were obtained from failing and control left ventricles by enzymatic dissociation as previously described (34, 35) . The apex (1-3 g) was excised and immediately frozen in liquid nitrogen for later protein and mRNA analysis. Only Ca 2ϩ -tolerant rod-shaped myocytes with clear cross striations and without spontaneous contractions or signification granulation were selected for experiments.
Solutions. The external solution for AP measurements contained (in mmol/l) 138 NaCl, 4 KCl, 2 CaCl2, 1 MgCl2, 10 glucose, 0.33 NaH 2PO4, and 10 HEPES (pH 7.4 with NaOH). The pipette solution for recording APs contained (in mmol/l) 140 KCl, 5 NaCl, 1 MgCl 2, 10 HEPES, 2 EGTA, and 4 MgATP (pH 7.4 with KOH).
For the measurement of I Ca,L and [Ca 2ϩ ]i,the extracellular solution contained (in mmol/l) 140 NaCl, 10 dextrose, 10 HEPES, 10 CsCl, 1 MgCl 2, and 1 CaCl2 (pH adjusted to 7.4 with NaOH). The intracellular solution contained (in mmol/l) 130 Cs-glutamate, 10 HEPES, 0.33 MgCl2, 4 Mg2ATP, and 0.05 indo-1 (Molecular Probes, Eugene, OR), and the pH was adjusted to 7.2 with CsOH.
For the measurement of NCX current, the extracellular solution contained (in mmol/l) 140 NaCl, 2 CaCl2, 2 MgCl2, 5 HEPES, 10 glucose (pH 7.4, adjusted by NaOH). In addition, Na ϩ -K ϩ -ATPase, K ϩ channels, and Ca 2ϩ channels were blocked with 20 mol/l ouabain, 1 mmol/l BaCl2, and 1 mol/l nifedipine, respectively. The electrogenic NCX current was inhibited by addition of 5 mmol/l Ni 2ϩ . The pipette solution contained (in mmol/l) 146 CsOH, 20 NaCl, 42 L-aspartic acid, 3 MgCl2, 10 HEPES, 20 TEA, 21 CaCl2, 42 EGTA, and 10 MgATP (pH 7.4, adjusted by CsOH). The free Ca 2ϩ concentration was 67 nmol/l (18).
[Ca 2ϩ ]i in the presence and absence of thapsigargin were measured in an extracellular solution containing (in mmol/l) 138 NaCl, 4 KCl, 1 MgCl 2, 2 CaCl2, 0.33 NaH2PO4, and 10 glucose (pH 7.4, adjusted by NaOH). The pipette solution contained (in mmol/l) 130 K glutamate, 9 KCl, 10 NaCl, 0.5 MgCl 2, and 5 MgATP (pH 7.2, adjusted by KOH) with 80 mol/l indo-1.
Electrophysiological recording techniques. The whole cell configuration of the patch-clamp technique was used. Myocytes were transferred to the stage of an inverted microscope and superfused with external solution at a rate of 1-2 ml/min. All recordings were performed at 37°C. Whole cell currents were recorded with an Axopatch 200A amplifier (Axon Instruments), low-pass filtered at 5 kHz, and digitized at 10 kHz via a Digidata 1200 A/D (Axon Instruments) interface for off-line analysis. Myocyte capacitance was calculated by integrating the area under an uncompensated capacity transient elicited by a 10-mV depolarizing pulse from a holding potential of Ϫ80 mV.
A xenon arc lamp was used to excite indo-1 fluorescence at 365 nm, and the ratio (R ϭ F405nm/F495nm) of the emitted fluorescence after subtraction of cellular autofluorescence was used to calculate free [Ca 2ϩ ]i according to the equation [Ca 2ϩ 
, where ␤ is ratio of free to bound indo-1 fluorescence at 495 nm, using a K d of 844 nmol/l, as reported for rabbit cardiomyocytes (7) . The average R min, Rmax, and ␤ for the fluorescence system were determined to be 0.4 Ϯ 0.4, 9.8 Ϯ 2.9, and 7.8 Ϯ 3.2 (n ϭ 6), respectively, as previously described (66) 21-23°C in the bath solution containing fluo-3 AM (10 mol/l) and pluronic acid (0.05% wt/vol). Fluo-3 was excited with an argon laser at a wavelength of 488 nm. The fluorescence emission was measured at wavelengths Ͼ515 nm.
The lateral and axial spatial resolutions of the confocal system equipped with a ϫ63 1.4-numerical aperture oil immersion objective lens were 0.25 and 0.52 m. Line scan images were created from a series of 512 lines with 256 pixels per line, 0.1 m per pixel, and 3.0 ms per line (including 0.5-ms reset time per scan); the pixel dwell times were 10.0 s. The scan line positions were selected to be in the middle of the myocyte, away from the edges and avoiding the nucleus. Sparks were sampled in rabbit ventricular myocytes according to the protocol used by Satoh et al. (71) . Briefly, myocytes were field stimulated every 6 s. Ca 2ϩ sparks were determined from the line scan images and sampled during the resting period following the overall Ca 2ϩ transient (see Fig. 3A ). Amplitude, duration, and width (spread in the axial direction) were determined for each Ca 2ϩ spark. Data from control animals were compared with those from failing animals, using the Mann-Whitney test for comparison of nonnormal distributions. The line scan images were analyzed with custom-made IDL routines.
mRNA measurements. The DNA fragments used to generate rabbitspecific riboprobes were amplified from reverse-transcribed total rabbit ventricular RNA with the polymerase chain reaction (PCR). The PCR products were cloned into pCR2.1 (Invitrogen) and, if necessary, subcloned into the EcoRI site of pSP70 (Promega). All constructs were confirmed by DNA sequencing. The Na ϩ channel template was designed to protect a fragment in the I-II linker of the Na ϩ channel that is unique to the cardiac isoform. The rabbit cardiac Na ϩ channel (rabNav1.5) probe spans nucleotides 1655 to 1801 (146 bp), and NCX (rabNCX) spans nucleotides 443 to 585 (142 bp) ( Table 1 ). For better discrimination of the fragment sizes, the probes were cut at the unique restriction sides (NgomI for rabNav1.5, BsaI for rabNCX), resulting in protected sequences of 78 and 116 bp for rabNav1.5 and rabNCX, respectively.
Ribonuclease protection assays (RPAs) were performed as previously described (39) . Total RNA was prepared with TRIzol reagent (GIBCO) according to the manufacturer's instructions. The integrity of all RNA samples was confirmed by analysis on a denaturing agarose gel and quantified by optical density measurements at 260 nm. Determinations were performed in duplicate on 10 g of RNA from each ventricular sample.
Steady-state mRNA levels were quantified by exposing the gels on a storage phosphor screen and then scanning on a phosphoimager (Molecular Dynamics); quantification of the transcript levels was performed with ImageQuant software (Molecular Dynamics). The level of the rabNCX gene expression is given as the relative density of the protected fragment normalized to the density of the control protected fragment (rabNav1.5), the cardiac isoform of the Na ϩ channel, thereby normalizing for both RNA loading and the fraction of the sample that is cardiac myocytes.
Fluorescence-based kinetic real-time PCR was performed, using a Perkin-Elmer Applied Biosystems model 7900 sequence-detection system to quantify mRNA levels as previously described (14) . Total RNA was isolated from the rabbit ventricle with Qiagen RNeasy with on-column DNase digestion. Each reporter signal was then divided by the fluorescence of an internal reference dye (ROX) to normalize for non-PCR-related fluorescence and to 18S rRNA to normalize for loading. All primers and probes are shown in Table 1 . The level of gene expression was normalized to a reference sample to permit comparison among samples.
Protein measurements. Quantification of SERCA2a, phospholamban (PLB), and NCX proteins was performed as previously described (14) . Frozen tissue samples were homogenized on ice in 10 ml/g of tissue (wt/wt) in lysis buffer containing (in mmol/l) 145 NaCl, 0.1 MgCl 2, 15 HEPES, and 10 EGTA (pH 7.0) and protease inhibitors (Complete, Boehringer Mannheim). The protein concentration was assayed with Protein-Assay (Bio-Rad). Quantification of RyR was performed on membrane preparations as previously described (58) . For separation of SERCA2a, PLB, and NCX lysates were run in triplicate on a 4 -15% polyacrylamide gradient gel (Bio-Rad), and for RyR membrane preparations were run on 3-8% Tris-acetate gel (Invitrogen). The same control sample was run on every gel to be used as a reference for normalization across blots. Nonspecific antibody binding was blocked for 1 h in phosphate-buffered saline (PBS) with Tween 20 and nonfat milk. The membranes were then incubated in Tween-PBS with the primary antibodies (polyclonal anti-Ca 2ϩ channel ␣1c antibody ACC-003, Alomone Labs; monoclonal antiSERCA2a antibody MA3-910, monoclonal anti-PLB antibody MA3-922, monoclonal anti-NCX antibody MA3-926, and monoclonal anti-RyR antibody MA3-916, Affinity BioReagents) and the appropriate horseradish peroxidase-conjugated secondary antibody. Proteins were detected with chemiluminescence on Hyperfilm-ECL (Amersham Life Science) or Lumi-Light Western Blotting Substrate (Roche). Films were digitally scanned; band densities were normalized to the average density of the reference lanes.
Statistical analysis. Pooled electrophysiological data are presented as means Ϯ SD, while protein and mRNA data are presented as means Ϯ SE. Statistical comparisons were made with unpaired t-tests (unless otherwise specified), with P Ͻ 0.05 considered to be statistically significant.
RESULTS

APD in control and failing myocardium.
We measured APD at 50% and 90% repolarization (APD 50 and APD 90 ) from 18 myocytes isolated from 12 control ventricles and 11 myocytes from 5 failing ventricles over a range of stimulation frequencies from 0.1 to 1.0 Hz. APD 50 and APD 90 of myocytes isolated from the midmyocardial layer of failing hearts were significantly longer than those of myocytes isolated from normal hearts at stimulation frequencies of 0.1 and 0.2 Hz (Fig. 1) ] i transients from control and failing hearts, elicited by voltage steps to Ϫ40, Ϫ20, 0, 20, and 40 mV from a holding potential of Ϫ100 mV with a prepulse to Ϫ50 mV to inactivate the Na ϩ current, are shown in Fig. 2A . The voltage dependence and kinetics of I Ca,L do not differ between myocytes isolated from control and failing hearts. The current-voltage relationships for I Ca,L measured in ventricular myocytes isolated from control and failing hearts reveal no significant difference in I Ca,L density (Fig. 2C) .
In contrast, the peak [Ca 2ϩ ] i in myocytes isolated from failing hearts were significantly depressed at test voltages Ն0 mV (Fig. 2B) sparks are reflected in the ratio of the peak to background fluorescences and were analyzed with the distribution histograms shown in Fig. 3C . Ca 2ϩ sparks in myocytes from the failing hearts were significantly smaller than those from control hearts (P Ͻ 0.0001, Mann-Whitney test of medians). There were no differences in Ca 2ϩ spark kinetics (i.e., width or duration) in cells isolated from control and failing animals (1.1 Ϯ 0.7 vs. 1.0 Ϯ 0.8 m and 22.6 Ϯ 11.8 vs. 22.4 Ϯ 13.8 ms, respectively). Finally, there was no difference in Ca 2ϩ spark frequency (obtained by dividing each of the histograms of Fig. 3B by its corresponding number of frames) between the two myocyte groups (Fig. 3D) , albeit the distribution corresponding to the failing myocytes appeared to be smaller.
Measurement of NCX current. NCX significantly contributes to the [Ca 2ϩ ] i and AP profile. We measured the NCX current with the voltage protocol shown in Fig. 4A . Rampwise changes in voltage (ϩ60 to Ϫ120 mV, 90 mV/s) were applied at a rate of 0.1 Hz from a holding potential of Ϫ30 mV. Under the experimental conditions used, the Ni 2ϩ -sensitive current is primarily through the exchanger (44) . Figure 4 , B and C, show representative current recordings in myocytes isolated from a control and a failing heart, respectively. After application of 5 mmol/l Ni 2ϩ , the current decreased (tracing b) compared with that in the absence of Ni 2ϩ (tracing a) (Fig. 4, B and C, top) . The difference currents (a Ϫ b) are shown in Fig. 4 , B and C, bottom, respectively. As demonstrated in the representative recordings and as summarized in Fig. 4D and Table 2 , there was no significant difference in the NCX current density in myocytes isolated from control and failing hearts. Reversal potentials did not differ between myocytes isolated from control and failing hearts (Ϫ28. ] i transients were elicited by 200-ms voltage-clamp steps to ϩ20 mV from a holding potential of Ϫ80 mV at a rate of 0.5 Hz before and 3 min after exposure to 10 mol/l thapsigargin.
As illustrated in transients in the myocytes isolated from the failing ventricles (Fig. 5B) were characterized by smaller peak amplitudes and slower decays compared with the myocytes isolated from control hearts. Thapsigargin further reduced the peak and prolonged the decay of [Ca 2ϩ ] i transients of the myocytes from failing hearts. In the baseline state, the time constant of decay of [Ca 2ϩ ] i ( Ca ) was significantly larger in myocytes isolated from failing myocardium. After inhibition of SERCA2a, Ca was comparable in myocytes from both groups (Fig. 5C ). The absolute increase in Ca was greater in myocytes isolated from the control hearts, but this difference did not reach statistical significance (Fig. 5D) . The relative increase in Ca with thapsigargin, however, was significantly larger in myocytes isolated from control compared with failing hearts (P Ͻ 0.05, Fig.  5D ). This result suggests that myocytes from failing hearts rely more on NCX for cytosolic Ca 2ϩ removal than myocytes isolated from control hearts, consistent with a defect in SR Ca 2ϩ uptake.
Measurement of Ca 2ϩ -handling mRNA and protein.
We measured mRNA and immunoreactive protein levels of the major Ca 2ϩ -handling proteins to better understand the molecular mechanisms of altered excitation-contraction coupling (ECC) in this model of HF.
I Ca,L ␣ 1c -subunit, RyR, SERCA2a, and PLB mRNA levels were measured with kinetic RT-PCR (Fig. 6B ). There was no significant difference in the level of ␣ 1c (Fig. 6A) or RyR (Fig.  6B ) mRNA in ventricular myocardium from control and failing hearts. However, the mRNA levels of SERCA2a (Fig. 6C) and PLB ( Fig. 6D) were significantly reduced in failing compared with control hearts (P Ͻ 0.05).
NCX mRNA was quantified by RPA; Fig. 6E shows a representative RPA comparing left ventricular apical samples from normal and failing hearts. There is sample-to-sample variation in both normal and failing hearts in rabNCX-as well as rabNav1.5-protected fragments; however, the summarized data (Fig. 6F ) reveal no significant difference in the steadystate level of NCX mRNA in failing compared with control myocardium.
Western blotting was used to measure the levels of immunoreactive Ca 2ϩ -handling proteins. We observed no difference in the level of ␣ 1c protein expression (Fig. 7A ) in tissues from control and failing hearts. There was a modest but statistically significant downregulation of the level of RyR (Fig. 7B) , SERCA2a (Fig. 7C) , and PLB monomer (Fig. 7D) proteins in failing compared with control ventricles. The antibody used in the NCX Western blots recognized three specific bands of ϳ160, ϳ120, and ϳ70 kDa (23); there is a 48% overall increase in immunoreactive protein in failing myocardium ( Fig. 7E ; P Ͻ 0.05). Values (in pA/pF) are means Ϯ SD. Control: no. of animals (N) ϭ 6, no. of myocytes (n) ϭ 18, capacitance (C) ϭ 151Ϯ48 pF; failing: N ϭ 5, n ϭ 18, C ϭ 160 Ϯ 47 pF.
DISCUSSION
The pacing tachycardia HF model typically yields dilated hearts, with depressed basal contractility and elevated diastolic pressures. Other dominant features of this model include a marked decline in systolic function, chamber dilation, a marked increase in end-diastolic pressure, and chamber remodeling. This model is also characterized by abnormal ␤-adrenergic receptor signaling (46) , elevated activity of the reninangiotensin-aldosterone pathway (56) , apoptosis (48) , and atrial and ventricular arrhythmias (67) . Therefore, this model recapitulates the phenotype of certain types of human HF manifested by depressed [Ca 2ϩ ] i transients and prolonged APs. The overall goal of this study was to probe the mechanism(s) responsible for the altered Ca 2ϩ homeostasis and cellular electrophysiology in a clinically relevant rabbit model of HF. We found that in myocytes from failing hearts the APD was longer and the I Ca,L density and NCX currents were unaltered, yet the Ca 2ϩ spark amplitude and [Ca 2ϩ ] i transients were smaller. Decay of [Ca 2ϩ ] i in myocytes isolated from control hearts exhibited a greater reliance on SR Ca 2ϩ uptake, consistent with aberrant uptake in cells from failing hearts (Fig. 5) . At the molecular level, we found that in the failing heart SERCA2a and PLB mRNA levels were downregulated as well as RyR, SERCA2a, and PLB protein levels, while NCX protein was upregulated. Overall, our data suggest that the development of HF in this model is associated with interrelated defects in both SR Ca 2ϩ uptake and release mechanisms that synergistically contribute to the phenotype observed in myocytes from failing hearts.
Trigger of SR Ca 2ϩ release. Compared with controls, we did not find any significant changes in the Ca 2ϩ trigger for SR Ca 2ϩ release in this model; namely, there were no significant reductions in I Ca,L density (Fig. 2C), mRNA (Fig. 6A) , and the immunoreactive ␣ 1C -subunit (Fig. 7A) .
Our data are entirely consistent with those in the canine pacing-induced HF model (40, 65) , human dilated cardiomyopathy (DCM), and ischemic cardiomyopathy (ICM) (8, 9, 60, 69) , all of which exhibit no change in I Ca,L density. However, some studies in the rabbit pacing-induced (80) and rat postmyocardial infarction (MI) (54) HF models have shown a reduction in I Ca,L density, and studies in human DCM and ICM have shown a frequency-dependent decrease in I Ca,L density (77) . Also, studies in human DCM and ICM (27, 79, 80) , the rabbit pacing-induced HF model (12) , and the rat (17) and canine (24) post-MI HF models have shown a decrease of the dihydropyridine (DHP) binding sites; however, they were found unaltered in the canine pacing-induced HF model (81) . The steady-state mRNA ␣ 1c level in the canine pacing-induced HF model (40) and the failing human heart has been reported to be unaltered (72), while it was found to be decreased in another study in the failing human heart (79).
Overall, it appears that differences among studies in the density of the I Ca,L or number of DHP binding sites can be attributed to differences in the severity of hypertrophy or failure.
SR Ca 2ϩ release. In this study, we have observed that the decrease in [Ca 2ϩ ] i (Figs. 2B and 5B) occurs despite the lack of a change in the trigger for Ca 2ϩ release, the L-type Ca ]i transients were evoked by 200-ms voltage-clamp steps to ϩ20 mV from a holding potential of Ϫ80 mV at a rate of 0.5 Hz in rabbit ventricular myocytes isolated from control (A) and failing (B) ventricular myocardium in the absence and presence of 10 mol/l thapsigargin. C: summarized data (Nc ϭ 3, nc ϭ 13; Nf ϭ 3, nf ϭ 16) demonstrate a substantial increase in the time constant of Ca 2ϩ removal from the myocyte (Ca) in myocytes isolated from failing compared with control ventricles under baseline conditions. Blocking Ca 2ϩ -ATPase with thapsigargin, however, increased the absolute Ca to a comparable value in both groups. D: there was a slightly but not statistically significantly larger increase in Ca in the control group. The relative increase in Ca with thapsigargin was significantly larger in control compared with failing myocardium Values are means Ϯ SD (*P Ͻ 0.05).
the reduction in Ca 2ϩ release (Fig. 5) . Alternatively, abnormal SR Ca 2ϩ release could be attributed to RyR downregulation (Fig. 7B) , or the ECC gain could be decreased in the failing myocytes. The role of the RyR in defective Ca 2ϩ handling in the failing heart has been controversial at the levels of both expression (25, 38, 62) and function (38, 57) . Although we found no significant difference in the steady-state levels of RyR mRNA (Fig. 6B ) between control and failing hearts, the protein level of RyR was significantly downregulated in the failing hearts (Fig. 7B) , suggesting that the downregulation of immunoreactive protein is not transcriptionally mediated in this model. On the other hand, while decreases in the ECC gain have been reported in failing rodent hearts (26), this observation has not been confirmed in large-animal models (34) or in human (51) HF studies.
Overall, the net result of the above scenarios would be smaller Ca 2ϩ spark amplitude and depressed [Ca 2ϩ ] i in myocytes from failing hearts. Ca 2ϩ sparks in myocytes from failing human hearts are characterized by a slower time to peak and half-time of decay and a larger full width at half-maximum, compared with control hearts (53) . In contrast to our previous findings in the hypertrophic heart (76), Ca 2ϩ sparks in myocytes isolated from the failing rabbit ventricle are smaller compared with the control heart (P Ͻ 0.0001), although the kinetics of the individual sparks were unchanged. Furthermore, we have shown that while the decreased [Ca 2ϩ ] i can be predominantly attributed to smaller Ca 2ϩ spark amplitude, a nonsignificant decrease in the Ca 2ϩ spark frequency (Fig. 3D ) could synergistically contribute to smaller [Ca 2ϩ ] i . The reduced frequency of sparks in myocytes from failing rabbit hearts is concordant with recently published data in human myocytes (53) . It is also important to note that the hypertrophyrelated (76) control and failing myocytes can entirely explain our results for the following reasons. First, as noted above, hypertrophyrelated increases in Ca 2ϩ spark amplitudes occurred without significant changes in SR calcium content. Second, our experimental conditions, namely the low stimulation frequency and prepulses, were chosen specifically to minimize any potential changes in SR Ca 2ϩ content and to insure a uniform, although not equal, SR Ca 2ϩ load. Finally, differences in [Ca 2ϩ ] i were observed at low stimulation frequencies when there is no difference in the SR Ca 2ϩ load between myocytes from normal and failing hearts (75) . Therefore, while we cannot entirely exclude the possibility that differences in SR Ca 2ϩ load between myocytes from normal and failing hearts contribute to our observed changes in [Ca 2ϩ ] i and Ca 2ϩ spark amplitude, we believe that defects in SR Ca 2ϩ release independently contribute to the altered Ca 2ϩ handling in this model. Cytosolic Ca 2ϩ removal. Our data are consistent with HF-associated changes in Ca 2ϩ handling (5, 8, 66) manifested by a reduction in the amplitude of [Ca 2ϩ ] i (Figs. 2C and 5B). We have observed a significant reduction in SERCA2a (Fig. 6C) and PLB (Fig. 6D ) mRNA levels, with unaltered NCX mRNA level. We also observed a reduction in SERCA2a protein ( Fig. 7C ; Refs. 31, 66) and PLB (Fig.   7C ) protein levels and a significant upregulation of the NCX protein level.
Despite agreement that Ca 2ϩ sequestration by the SR is defective in the failing myocardium, there is significant controversy about the molecular mechanisms. SERCA2a mRNA is decreased in a rat hypertrophy model (20) and human DCM and ICM (2, 20, 22, 28, 47, 52, 59, 73, 78, 79, 85) , but some studies of human DCM have shown no change of the SERCA2a mRNA (63, 73, 74) . Fewer studies have shown a reduction in the immunoreactive protein in the rat, rabbit, and canine post-MI HF models (13, 28, 31, 45, 66, 85) , while some studies of human DCM have shown no change in SERCA2a protein (63, 73, 74) .
Indeed, a decrease in the SERCA2a-to-PLB ratio has been associated with defective Ca 2ϩ handling and contraction in several models of cardiac hypertrophy and failure (29, 30, 37, 61) . While we found that the SERCA-to-PLB mRNA ratio was significantly decreased compared with controls (1.71 Ϯ 0.46 vs. 2.37 Ϯ 0.65, P Ͻ 0.05) the ratio of SERCA2a to PLB protein did not change between the two groups (1.08 Ϯ 0.29 and 0.93 Ϯ 0.16, respectively). Therefore, we cannot attribute the changes in Ca 2ϩ handling we observed in our model to changes in the SERCA2a-to-PLB protein ratio. NCX constitutes the primary mode of extrusion of Ca 2ϩ from the myocyte and is critically important to Ca 2ϩ handling in the normal and the failing heart. In the rabbit pacing-induced HF model, NCX protein is significantly increased (Fig. 7E) . This is qualitatively and quantitatively consistent with previous reports in failing human hearts from patients with ICM (21, 78) or DCM (70) and the canine pacing-induced (3, 35, 66) and rat post-MI (54) HF models. However, the increase in NCX protein was not associated with a change in the level of mRNA, in contrast to other studies (68, 84) , which may be explained by altered turnover resulting in an increase in NCX protein.
Overall, our data support the conclusion that the abnormalities of Ca 2ϩ handling that we observed in the rabbit rapid pacing model of HF can be attributed mainly to proximate abnormalities of the SR Ca 2ϩ release mechanism that are further exacerbated by reduced SR Ca 2ϩ uptake, for the following reasons. First, we observed changes in the peak amplitudes of [Ca 2ϩ ] i transients (Fig. 2B ) rather than changes in decay rates (Fig. 5D) . Second, we observed decreases in the amplitudes of Ca 2ϩ sparks under conditions where differences in the Ca 2ϩ content of the SR are predicted to be small (75) . Third, we found a downregulation of RyR, SERCA2a, and PLB, but an unaltered SERCA2a-to-PLB protein ratio and unchanged NCX current density.
Summary and significance. The heart failure literature is replete with multiple conflicting reports regarding the mechanisms that underlie the observed abnormalities in Ca 2ϩ homeostasis, AP prolongation, and predisposition to life-threatening arrhythmias both in animal models of HF and in the failing human heart. The differences between these conflicting reports reflect, in part, the fact that distinct molecular abnormalities converge to a common HF phenotype. Such molecular abnormalities are often the result of distinct and divergent "insults" and "injuries" to the myocardium, which may produce HF phenocopies. The differential "trigger" events seen in animal HF models parallel that seen in human HF of different etiologies. Thus understanding the molecular mechanisms of these trigger events has important implications in the treatment of HF patients resulting from different etiologies. These differences are further compounded by species differences in the expression and function of major Ca 2ϩ cycling molecules and by differences in the spatiotemporal progression and severity of the disease.
The findings of the present study support the notion that pacing-induced HF in the rabbit results from a distinct mixed mechanism (namely, prominent abnormalities in SR Ca 2ϩ release and uptake) compared with HF that is a consequence of prolonged pressure and/or volume overload (where abnormalities in SR Ca 2ϩ uptake predominate). These observations, then, challenge the conventional wisdom that cardiac hypertrophy and systolic dysfunction are two different set points on the continuous slippery slope of cellular failure that leads inexorably to symptomatic HF.
Therefore, this requires not only identification of the disease gene(s), but eventually connection of the gene(s) to molecular pathways that initiate, promote, suppress, and potentially reverse surrogate end points of the disease phenotype. Such a process is likely to clarify the distinction between true mechanisms and mere markers of HF, a distinction that has farreaching preventive and therapeutic implications.
Study limitations.
The single most important limitation of this study is the lack of direct information regarding the SR Ca 2ϩ content. However, the fact that we observed only changes in the peak amplitude of [Ca 2ϩ ] i , rather than in its decay rate, at low stimulation frequencies suggests no or minimal differences in the SR Ca 2ϩ load among myocytes from normal and failing hearts. Furthermore, given that in slowly stimulated myocytes from normal and failing hearts the difference in SR Ca 2ϩ content is minimized (75), we are inclined to believe that the SR Ca 2ϩ content in the Ca 2ϩ spark experiments is very similar. Thus it would not alter the interpretation of our results pertaining to the abnormal SR Ca 2ϩ release, even if the SR Ca 2ϩ content is profoundly reduced in these myocytes.
In the present study the whole cell patch-clamp technique was used to measure L-type Ca 2ϩ and NCX current densities. The whole cell patch-clamp technique permits direct measurement of the currents in an intact cardiac myocyte; however, this method will alter the cytosolic composition. Although this artifact is equally applied to both control and failing myocytes, we cannot exclude the possibility that the Ca 2ϩ and NCX currents are differentially modulated by cytoplasmic mediators in control and failing myocardium (15, 16) .
Furthermore, in the experiments to measure NCX current density [Ca 2ϩ ] i was clamped by a high concentration of EGTA in the pipette solution. Ca 2ϩ is an important regulator of the activity of the NCX (33, 35) mediated by a high-affinity Ca 2ϩ binding site composed of acidic residues in the large intracellular loop of the NCX (49) . Since this Ca 2ϩ affinity site is intrinsic to the NCX, it is unlikely that a difference in current density of the NCX between myocytes isolated from control and failing hearts would become apparent at higher [Ca 2ϩ ] i . However, our data do not rigorously exclude this possibility.
